← Back to headlines
Ugandan Company Secures Seven US Patents for mRNA Cancer Vaccine
A biotech firm based in Uganda has successfully filed multiple patents in the United States for a novel mRNA-based therapeutic targeting cancer, marking a significant milestone in African pharmaceutical innovation.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Genetically Modified Pig Kidney Sustains Patient for Record Nine Months
28m ago
UNICEF Report Finds 20 Million Children Annually Face Online Sexual Exploitation
1h ago
Pentagon Temporarily Rescinds Testosterone Screening Guidance for Troops
4h ago
RFK Jr. Allegedly Requested Removal of Measles Deaths From CDC Tally
5h ago